Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.374
Neutral
RSI(14)
50.377
Neutral
STOCH(KDJ)(9,3,3)
71.487
Neutral
ATR(14)
2.476
Low Volatility
CCI(14)
21.101
Neutral
Williams %R
40.940
Buy
TRIX(12,20)
0.004
Sell
StochRSI(14)
0.000
Sell
Search
LivaNova PLC
LIVNAdd to Watchlist
80.140USD
-0.910-1.12%
Close 07-31 16:00（ET）Quotes delayed by 15 min
4.40BMarket Cap
40.53P/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-1.12%
5 Days
+2.49%
1 Month
-2.84%
6 Months
+21.96%
Year to Date
+30.25%
1 Year
+94.85%
Key Figures
80.560Open
81.780High
514.70KVolume
40.53P/E TTM
16.87P/E Dynamic
--Dividend TTM
0.94%Turnover Ratio
81.050Prev. Close
79.294Low
30.95MTurnover
69.58P/E Static
3.63P/B
0.00%Div Yield TTM
4.22%ROA
75.81552wk High
0.96Volume Ratio
63.23MNet Profit
54.90MShares
1.9772EPS TTM
0.87Beta
9.54%ROE
41.01552wk Low
3.07%Amplitude
67.29%Gross Margin
4.40BMarket Cap
-1.85Reward/Risk
1.92%Risk Rate
TradingKey Stock Score of LivaNova PLC
Currency: USD Updated: 2026-07-31Key Insights
LivaNova PLC's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 22 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 84.93.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
LivaNova PLC's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
LivaNova PLC Highlights
StrengthsRisks
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 20.33% year-on-year.
Turnaround to Loss
The company's performance has turned to a loss, with the latest annual loss of USD .
Fairly Valued
The company’s latest PE is 40.53, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 60.49M shares, decreasing 15.69% quarter-over-quarter.
Held by HOTCHKIS & WILEY
Star Investor HOTCHKIS & WILEY holds 478.62K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.16.
Analyst Rating
Based on
10
analysts
Buy
Current Rating
84.933
Target Price
+4.30%
Upside Space
LivaNova PLC News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
10
analysts
Buy
Current Rating
84.933
Target Price
+4.30%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
LivaNova PLC
LIVN
10
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Medtronic PLC
MDT
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Indicators
Moving Average
Indicators
Value
Direction
MA5
81.058
Sell
MA10
79.942
Buy
MA20
80.931
Sell
MA50
78.791
Buy
MA100
71.627
Buy
MA200
66.461
Buy
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
LivaNova PLC Info
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
Ticker SymbolLIVN
CompanyLivaNova PLC
CEOMakatsaria (Vladimir A)
Websitehttps://www.livanova.com/
Shareholders
Related Instruments
-1.72%
-0.43%
+0.12%
-0.59%
-0.74%
+0.10%
-6.42%
-0.36%
+1.75%
-0.14%
-2.99%
+1.58%
-0.29%
-1.02%
+0.13%
+0.05%
-0.80%
-0.24%
-0.70%
-0.78%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of LivaNova PLC (LIVN)?
The current price of LivaNova PLC (LIVN) is 80.14.
What is the symbol of LivaNova PLC?
The ticker symbol of LivaNova PLC is LIVN.
What is the 52-week high of LivaNova PLC?
The 52-week high of LivaNova PLC is 75.81.
What is the 52-week low of LivaNova PLC?
The 52-week low of LivaNova PLC is 41.02.
What is the market capitalization of LivaNova PLC?
The market capitalization of LivaNova PLC is 4.40B.
Is LivaNova PLC (LIVN) currently rated as Buy, Hold, or Sell?
According to analysts, LivaNova PLC (LIVN) has an overall rating of Buy, with a price target of 84.93.
What is the Earnings Per Share (EPS TTM) of LivaNova PLC (LIVN)?
The Earnings Per Share (EPS TTM) of LivaNova PLC (LIVN) is -4.45.